These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32256653)

  • 1. Network Pharmacology-Based Strategy for Predicting Therapy Targets of Traditional Chinese Medicine Xihuang Pill on Liver Cancer.
    Zhao X; Hao J; Chen S
    Evid Based Complement Alternat Med; 2020; 2020():6076572. PubMed ID: 32256653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target and Mechanism of the Xihuang Pill Based on Network Pharmacology for Lung Squamous Cell Carcinoma.
    Tu H; Li J; Xu W; Wang Z; Wang L
    Altern Ther Health Med; 2023 Oct; 29(7):148-154. PubMed ID: 37442189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study on molecular mechanism of Xihuang pill in the treatment of glioblastoma based on network pharmacology and validation in vitro and in vivo.
    Xu HB; Chen XZ; Zhu SY; Xue F; Zhang YB
    J Ethnopharmacol; 2024 Apr; 323():117675. PubMed ID: 38159819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network Pharmacology-Oriented Identification of Key Proteins and Signaling Pathways Targeted by Xihuang Pill in the Treatment of Breast Cancer.
    Wu J; Luo D; Li S
    Breast Cancer (Dove Med Press); 2020; 12():267-277. PubMed ID: 33324095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Based on BATMAN-TCM to Explore the Molecular Mechanism of Xihuang Pill Regulating Immune Function to Treat Breast Precancerous Lesions.
    Li D; Fan H; Dong J; Sun C; Su Y; Liu J; Gu Y
    Breast Cancer (Dove Med Press); 2021; 13():725-742. PubMed ID: 34992452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network Pharmacology-Based Identification of Key Mechanisms of Xihuang Pill in the Treatment of Triple-Negative Breast Cancer Stem Cells.
    Zhang YZ; Yang JY; Wu RX; Fang C; Lu H; Li HC; Li DM; Zuo HL; Ren LP; Liu XY; Xu R; Wen JH; Huang HD; Hong R; Chen QJ
    Front Pharmacol; 2021; 12():714628. PubMed ID: 34737698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on the Potential Molecular Mechanism of Xihuang Pill in the Treatment of Pancreatic Cancer Based on Network Pharmacology and Bioinformatics.
    Wang J; Zhang Y; Wang Q; Wang L; Zhang P
    Evid Based Complement Alternat Med; 2022; 2022():4651432. PubMed ID: 35449823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xihuang pill in the treatment of cancer: TCM theories, pharmacological activities, chemical compounds and clinical applications.
    Xu HB; Chen XZ; Wang X; Pan J; Yi-Zhuo Z; Zhou CH
    J Ethnopharmacol; 2023 Nov; 316():116699. PubMed ID: 37257709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systems pharmacology in combination with proteomics reveals underlying mechanisms of Xihuang pill against triple-negative breast cancer.
    Xu X; Zhang J; Zhang Z; Wang M; Liu Y; Li X
    Bioengineered; 2020 Dec; 11(1):1170-1188. PubMed ID: 33092442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prospect of
    Chen Z; Li Z; Yang S; Wei Y; An J
    Heliyon; 2023 Apr; 9(4):e15490. PubMed ID: 37128341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilising network pharmacology to explore the underlying mechanism of Wumei Pill in treating pancreatic neoplasms.
    Wan Y; Xu L; Liu Z; Yang M; Jiang X; Zhang Q; Huang J
    BMC Complement Altern Med; 2019 Jul; 19(1):158. PubMed ID: 31272505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xihuang pill potentiates the anti-tumor effects of temozolomide in glioblastoma xenografts through the Akt/mTOR-dependent pathway.
    Fu J; Zhu SH; Xu HB; Xu YQ; Wang X; Wang J; Kong PS
    J Ethnopharmacol; 2020 Oct; 261():113071. PubMed ID: 32603676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the Regulation Mechanism of Xihuang Pill,
    Yang K; Zeng L; Ge A; Bao T; Xu T; Xie X; Liu L
    Front Pharmacol; 2020; 11():825. PubMed ID: 32595497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the mechanism of Shenqisherong pill against cervical spondylotic myelopathy by network pharmacology and molecular docking.
    Li G; Sun YL; Sng KS; Zheng Z; Wang YJ; Yao M; Cui XJ
    Ann Palliat Med; 2021 Oct; 10(10):10253-10275. PubMed ID: 34498478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network pharmacology evaluation of the active ingredients and potential targets of XiaoLuoWan for application to uterine fibroids.
    Yu Y; Yang F; Liu H
    Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33196098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of potential bioactive compounds and mechanisms of GegenQinlian decoction on improving insulin resistance in adipose, liver, and muscle tissue by integrating system pharmacology and bioinformatics analysis.
    Cao Z; Zeng Z; Wang B; Liu C; Liu C; Wang Z; Li S
    J Ethnopharmacol; 2021 Jan; 264():113289. PubMed ID: 32846191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
    Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
    J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frankincense myrrh attenuates hepatocellular carcinoma by regulating tumor blood vessel development through multiple epidermal growth factor receptor-mediated signaling pathways.
    Zheng P; Huang Z; Tong DC; Zhou Q; Tian S; Chen BW; Ning DM; Guo YM; Zhu WH; Long Y; Xiao W; Deng Z; Lei YC; Tian XF
    World J Gastrointest Oncol; 2022 Feb; 14(2):450-477. PubMed ID: 35317323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Integrative Metabolomic and Network Pharmacology Study Revealing the Regulating Properties of Xihuang Pill That Improves Anlotinib Effects in Lung Cancer.
    Li C; Wang Z; Chen W; Cao B; Zhang M; Gu Q; Qi S; Fei X; Shi Y; Li X; Li R; Wang J; Li G
    Front Oncol; 2021; 11():697247. PubMed ID: 34434895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanism action of Chinese herbal compound and target network pharmacology of
    Li M; Shi XL; Xu C; Wu LG; He B; Li YH; Liang BC
    Zhongguo Gu Shang; 2020 Oct; 33(10):933-7. PubMed ID: 33107256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.